Search results for: 'drug monetization market to real'

The expansion of embedded payment to new domains and process automation are great opportunities for growth in the Asia-Pacific Real-Time Payment (RTP) Monetization market. Technology advances in online payment and the development of cloud and API-based solutions are transforming the industry and its processing workflows. As a result, businesses wil...

06 Jul 2023  |  Asia Pacific  |  Market Research

Asia-Pacific Real-time Payment Growth Opportunities

Disruptive Technologies that Enable Open Banking are Fueling the Growth of Real-time Payments

Infographics

×

This research service examines the real-time payment (RTP) market in the Asia-Pacific (APAC). It identifies key customer needs and market trends and provides a country-wise analysis of relevant developments. RTP or fast-payment systems involve payment transactions that are initiated and processed in near real time or within minutes. Unlike traditio...

The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...

20 Nov 2024  |  Global  |  Market Research

Ecosystem Activity for Automotive Data Monetization, 2024–2030

OEMs and Solution Providers are Developing New Concepts and Approaches to Re-invent the Vehicle Data Monetization Market

Infographics

×

In a competitive, yet fragmented market for vehicle data, partnerships with third parties can be the difference between a successful or failed strategy for original equipment manufacturers (OEMs). Inflated expectations linked to the value of vehicle data that marked the peak hype years for data monetization are well behind the automotive industry....

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

This research service overviews the global ADC market and provides a 6-year revenue forecast from 2023 to 2028. An ADC comprises multiple components such as the antibody, conjugation chemistry, linker, and payload. Many companies are working on each component while others only develop ADCs, which makes the market highly competitive. The development...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...

05 Sep 2022  |  Global  |  Technology Research

Technology Growth Opportunities for Exosome-Mediated Drug Delivery

Exosomes Are Promising Delivery Carriers for Advanced Therapeutics

Infographics

×

Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...